ARATANA THERAPEUTICS, INC. 4
4 · ARATANA THERAPEUTICS, INC. · Filed Jul 2, 2013
Insider Transaction Report
Form 4
Vander Vort John
Director10% Owner
Transactions
- Purchase
Common Stock
2013-07-02$6.00/sh+500,000$3,000,000→ 4,351,050 total(indirect: See Footnote) - Conversion
Series C Preferred Stock
2013-07-02−375,000→ 0 total(indirect: See Footnote)→ Common Stock (225,631 underlying) - Conversion
Common Stock
2013-07-02+2,406,739→ 2,823,173 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2013-07-02−1,333,333→ 0 total(indirect: See Footnote)→ Common Stock (802,246 underlying) - Conversion
Common Stock
2013-07-02+802,246→ 3,625,419 total(indirect: See Footnote) - Conversion
Common Stock
2013-07-02+225,631→ 3,851,050 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2013-07-02−4,000,000→ 0 total(indirect: See Footnote)→ Common Stock (2,406,739 underlying)
Footnotes (15)
- [F1]The shares are held as follows: 2,316,738 by MPM BioVentures V, L.P. ("BV V") and 90,001 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC and MPM BioVentures V LLC ("BV LLC") are the direct and indirect general partners of BV V and BV LLC is the manager of AM BV5. The Reporting Person is a member of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F10]The shares are held as follows: 4,188,029 by BV V and 163,021 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F11]The shares of Series A Preferred Stock were held as follows: 3,850,418 by BV V and 149,582 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F12]Immediately.
- [F13]Not applicable.
- [F14]The shares of Series B Preferred Stock were held as follows: 1,283,473 by BV V and 49,860 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F15]The shares of Series C Preferred Stock were held as follows: 360,977 by BV V and 14,023 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F2]Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.6016847 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The shares had no expiration date.
- [F3]Immediately prior to the closing of the Issuer's initial public offering, the Issuer issued shares of its Common Stock to the holders of its Series A, B and C Preferred Stock in satisfaction of accumulated and unpaid dividends. Includes the following shares: 226,794 by BV V and 9,135 by AM BV5.
- [F4]The shares are held as follows: 2,717,287 by BV V and 105,886 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F5]The shares are held as follows: 772,246 by BV V and 30,000 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F6]The shares are held as follows: 3,489,533 by BV V and 135,886 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F7]The shares are held as follows: 217,194 by BV V and 8,437 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F8]The shares are held as follows: 3,706,727 by BV V and 144,323 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F9]The shares were purchased as follows: 481,302 by BV V and 18,698 by AM BV5.